Cardiovascular Section, Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
Cardiovascular Section, Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
Prog Cardiovasc Dis. 2021 Mar-Apr;65:9-14. doi: 10.1016/j.pcad.2021.02.010. Epub 2021 Feb 22.
Aorto-iliac disease is a common manifestation of atherosclerosis. Individuals with this condition are at heightened cardiovascular risk, and may have limb symptoms ranging from claudication to limb-threatening ischemia. A regimen of medical therapy, risk factor modification, and exercise is first line therapy. Revascularization is reserved for individuals with lifestyle-limiting claudication despite conservative therapy and in those with chronic limb-threatening ischemia. Multiple endovascular therapies are now available that enable even the most complex aorto-iliac lesions to be approached and treated with safe and durable results.
主髂动脉疾病是动脉粥样硬化的常见表现。患有这种疾病的个体心血管风险增加,可能会出现从跛行到肢体威胁性缺血等症状。药物治疗、危险因素改变和运动是一线治疗方法。血管重建术保留给生活方式受限的跛行患者,即使是最复杂的主髂动脉病变也可以安全且持久地治疗。目前有多种血管内治疗方法,可用于治疗最复杂的主髂动脉病变。